177 related articles for article (PubMed ID: 24550687)
1. CDK5 and its activator P35 in normal pituitary and in pituitary adenomas: relationship to VEGF expression.
Xie W; Wang H; He Y; Li D; Gong L; Zhang Y
Int J Biol Sci; 2014; 10(2):192-9. PubMed ID: 24550687
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas.
Xie W; Liu C; Wu D; Li Z; Li C; Zhang Y
Oncotarget; 2016 Aug; 7(32):50883-50894. PubMed ID: 27438154
[TBL] [Abstract][Full Text] [Related]
3. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.
Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408
[TBL] [Abstract][Full Text] [Related]
4. The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte.
He Y; Li HL; Xie WY; Yang CZ; Yu AC; Wang Y
Glia; 2007 Apr; 55(6):573-83. PubMed ID: 17295212
[TBL] [Abstract][Full Text] [Related]
5. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells.
Ubeda M; Kemp DM; Habener JF
Endocrinology; 2004 Jun; 145(6):3023-31. PubMed ID: 14976144
[TBL] [Abstract][Full Text] [Related]
6. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
[TBL] [Abstract][Full Text] [Related]
7. Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas.
Viacava P; Gasperi M; Acerbi G; Manetti L; Cecconi E; Bonadio AG; Naccarato AG; Acerbi F; Parenti G; Lupi I; Genovesi M; Martino E
J Endocrinol Invest; 2003 Jan; 26(1):23-8. PubMed ID: 12602530
[TBL] [Abstract][Full Text] [Related]
8. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
9. Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway.
Demelash A; Rudrabhatla P; Pant HC; Wang X; Amin ND; McWhite CD; Naizhen X; Linnoila RI
Mol Biol Cell; 2012 Aug; 23(15):2856-66. PubMed ID: 22696682
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke.
Mitsios N; Pennucci R; Krupinski J; Sanfeliu C; Gaffney J; Kumar P; Kumar S; Juan-Babot O; Slevin M
Brain Pathol; 2007 Jan; 17(1):11-23. PubMed ID: 17493033
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP and Polyamines Overcome Inhibition by Myelin-Associated Glycoprotein through eIF5A-Mediated Increases in p35 Expression and Activation of Cdk5.
He H; Deng K; Siddiq MM; Pyie A; Mellado W; Hannila SS; Filbin MT
J Neurosci; 2016 Mar; 36(10):3079-91. PubMed ID: 26961960
[TBL] [Abstract][Full Text] [Related]
12. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.
Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis.
Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC
PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491
[TBL] [Abstract][Full Text] [Related]
14. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
Lee JH; Kim KT
J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35.
Utreras E; Futatsugi A; Rudrabhatla P; Keller J; Iadarola MJ; Pant HC; Kulkarni AB
J Biol Chem; 2009 Jan; 284(4):2275-84. PubMed ID: 19049962
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas.
Jin Kim Y; Hyun Kim C; Hwan Cheong J; Min Kim J
Tumori; 2011; 97(5):639-46. PubMed ID: 22158497
[TBL] [Abstract][Full Text] [Related]
17. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.
Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI
J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551
[TBL] [Abstract][Full Text] [Related]
18. Microtubule association of the neuronal p35 activator of Cdk5.
Hou Z; Li Q; He L; Lim HY; Fu X; Cheung NS; Qi DX; Qi RZ
J Biol Chem; 2007 Jun; 282(26):18666-70. PubMed ID: 17491008
[TBL] [Abstract][Full Text] [Related]
19. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
[TBL] [Abstract][Full Text] [Related]
20. TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas.
Xiao Z; Liu Q; Mao F; Wu J; Lei T
Int J Mol Sci; 2011; 12(6):4165-79. PubMed ID: 21747731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
